The Pharmacy Benefit Management Market expansion is fueled by three primary forces: rising prescription drug costs, increasing chronic disease prevalence, and rapid technological advancement. Prescription medication spending in the U.S. alone reached approximately USD 335 billion in 2021, with specialty drugs accounting for over 50% of total pharmacy expenditure. This cost pressure drives...

The Pharmacy Benefit Management Market is increasingly exploring international expansion as domestic market maturation, regulatory intensity, and pricing pressure drive growth-seeking strategies in foreign healthcare systems facing similar pharmaceutical cost challenges. While the PBM model originated and matured in the United States, countries with multi-payer insurance systems,...